| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Merck & Co., Inc. | EVP, Chief Patient Officer | Common Stock | 48.7K | $5.82M | $119.43 | Feb 24, 2022 | Direct |
| HilleVax, Inc. | Director | Stock Option | 22.5K | Jun 7, 2023 | Direct | ||
| CERNER Corp | Director | Common Stock | 0 | $95.00 | Jun 7, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| HLVX | HilleVax, Inc. | Jun 7, 2023 | 1 | $0 | 4 | Jun 9, 2023 | Director |
| HLVX | HilleVax, Inc. | Aug 19, 2022 | 1 | $0 | 4 | Aug 23, 2022 | Director |
| CERN | CERNER Corp | Jun 7, 2022 | 1 | -$1.43M | 4 | Jun 9, 2022 | Director |
| HLVX | HilleVax, Inc. | Apr 28, 2022 | 0 | $0 | 3 | Apr 28, 2022 | Director |
| MRK | Merck & Co., Inc. | Feb 24, 2022 | 1 | $702K | 4 | Feb 28, 2022 | EVP, Chief Patient Officer |
| MRK | Merck & Co., Inc. | Nov 1, 2021 | 9 | -$8.46M | 4 | Nov 3, 2021 | EVP, Chief Patient Officer |
| AFTR | AfterNext HealthTech Acquisition Corp. | Aug 11, 2021 | 0 | $0 | 3 | Aug 11, 2021 | Director |
| CERN | CERNER Corp | May 19, 2021 | 1 | $0 | 4 | May 20, 2021 | Director |